In low-resource settings, TLA can be applied for the rapid detection of resistance to INH, RMP and fluoroquinolones. Further studies are necessary to improve sensitivity to KM and further assess its performance for OFX and other drugs and its applicability in field conditions. K E Y W O R D S : resistance detection; non-commercial method; tuberculosis; MDR-TB; XDR-TB TO IMPROVE THE DETECTION of multidrugresistant tuberculosis (MDR-TB), the World Health Organization (WHO) recommends the use of the Xpert w MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) and line-probe assays (LPA) such as GenoType w MTBDRplus (Hain LifeSciences, Nehren, Germany). 1,2 Whereas Xpert detects rifampicin (RMP) resistance directly from specimens, MTBDRplus detects resistance to both isoniazid (INH) and RMP; however, it can be applied directly only to decontaminated smear-positive samples. Nucleic acid amplification tests (NAAT) are highly sensitive, but do not eliminate the need for culture and drug susceptibility testing (DST) required to test other drugs and to monitor patients during treatment. 3 MTBDRsl (Hain LifeSciences) is the only commercial assay available for the rapid detection of second-line drug resistance. However, as its use in optimising individualised patient regimens has not been endorsed yet, 4 DST for these drugs still relies on phenotypic testing. 2 In 2009, the WHO assessed the performance of non-commercial methods such as the colorimetric redox indicator (CRI) method, microscopic observation drug susceptibility (MODS) assay, nitrate reductase assay (NRA) and thin-layer agar (TLA). CRI, MODS and NRA have been recognised as valid methods, but were recommended only as interim solutions for reference laboratories. 5 The results for TLA were considered insufficient to draw conclusions about its performance and feasibility. 5 The TLA method uses 7H11 agar plates directly inoculated with decontaminated smear-positive specimens. Reading by conventional light microscopy permits rapid detection of growth without opening the plates, thereby reducing the biohazard risk. Two studies report high performance of TLA in the isolation of Mycobacterium tuberculosis complex (MTC) and detection of direct resistance; however, either the sample size was limited, 6 or the plates were read by the naked eye, increasing time to detection. 7 Another study has used TLA DST as an indirect test for RMP, ofloxacin (OFX) and kanamycin (KM). 8 However, the performance of TLA in direct DST against OFX and KM remains unknown.
prevalence of multidrug-resistant tuberculosis (TB) was 30 of 164 patients (18.3%), 2 (6.7%) of whom had extensively drug-resistant TB. R E S U LT S : TLA showed 94.7%, 98.2%, 100% and 78.9% sensitivity, respectively, for INH, RMP, OFX and KM, with 100% specificity. Average time to results was 7 days in TLA, 23 in MGIT and 49 for 7H11 agar.
C O N C L U S I O N S :
In low-resource settings, TLA can be applied for the rapid detection of resistance to INH, RMP and fluoroquinolones. Further studies are necessary to improve sensitivity to KM and further assess its performance for OFX and other drugs and its applicability in field conditions. K E Y W O R D S : resistance detection; non-commercial method; tuberculosis; MDR-TB; XDR-TB TO IMPROVE THE DETECTION of multidrugresistant tuberculosis (MDR-TB), the World Health Organization (WHO) recommends the use of the Xpert w MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) and line-probe assays (LPA) such as GenoType w MTBDRplus (Hain LifeSciences, Nehren, Germany). 1, 2 Whereas Xpert detects rifampicin (RMP) resistance directly from specimens, MTBDRplus detects resistance to both isoniazid (INH) and RMP; however, it can be applied directly only to decontaminated smear-positive samples. Nucleic acid amplification tests (NAAT) are highly sensitive, but do not eliminate the need for culture and drug susceptibility testing (DST) required to test other drugs and to monitor patients during treatment. 3 MTBDRsl (Hain LifeSciences) is the only commercial assay available for the rapid detection of second-line drug resistance. However, as its use in optimising individualised patient regimens has not been endorsed yet, 4 DST for these drugs still relies on phenotypic testing. 2 In 2009, the WHO assessed the performance of non-commercial methods such as the colorimetric redox indicator (CRI) method, microscopic observation drug susceptibility (MODS) assay, nitrate reductase assay (NRA) and thin-layer agar (TLA). CRI, MODS and NRA have been recognised as valid methods, but were recommended only as interim solutions for reference laboratories. 5 The results for TLA were considered insufficient to draw conclusions about its performance and feasibility. 5 The TLA method uses 7H11 agar plates directly inoculated with decontaminated smear-positive specimens. Reading by conventional light microscopy permits rapid detection of growth without opening the plates, thereby reducing the biohazard risk. Two studies report high performance of TLA in the isolation of Mycobacterium tuberculosis complex (MTC) and detection of direct resistance; however, either the sample size was limited, 6 or the plates were read by the naked eye, increasing time to detection. 7 Another study has used TLA DST as an indirect test for RMP, ofloxacin (OFX) and kanamycin (KM). 8 However, the performance of TLA in direct DST against OFX and KM remains unknown.
In the present study, we assessed the performance of direct TLA DST in detecting INH and RMP resistance compared to indirect MGITe (Mycobacteria Growth Indicator Tube; BD, Sparks, MD, USA), and in detecting OFX and KM resistance compared to indirect 7H11 agar. Discrepant results were resolved using a composite reference standard (CRS) consisting of the determination of minimal inhibitory concentration (MIC) and target gene sequencing. In addition, we compared the processing time and the cost of TLA to gold standard methods.
MATERIALS AND METHODS

Study design
All patients aged 715 years with at least one smearpositive sputum sample on Ziehl-Neelsen (ZN) staining in the National Reference Laboratory (NRL) of Tbilisi, Georgia, who had not received anti-tuberculosis treatment in the previous month, were eligible for the study. After providing informed consent, patients submitted two additional sputum samples which, if smear-positive, were refrigerated until shipment at ambient temperature to the Mycobacteriology Laboratory of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium. Only samples confirmed as smear-positive by the ITM were included in the study.
The study protocol was approved by the Institutional Review Board of the ITM, Antwerp, the Ethics Committee of the University Hospital of Antwerp, Belgium, and the Ethics Committee of the Georgian National Centre for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Laboratory procedures
In ITM, the samples were decontaminated with a final concentration of 1.5% N-acetyl-L-cysteinesodium hydroxide. After centrifugation for 20 min at 3000 g, the sediment was re-suspended in 1 ml distilled water. One drop was used to prepare a ZN smear and 500 ll was inoculated in MGIT culture according to the manufacturer's protocol. The remaining suspension was diluted 1:5 in sterile distilled water, and 100 ll was inoculated into each of the six wells of a TLA plate (Corning Costar 3516; SigmaAldrich, St Louis, MI, USA), which consisted of one well for growth control (GC), one well for each drug and one well for p-nitrobenzoic acid (PNB) to differentiate between MTC and non-tuberculous mycobacteria (NTM). Plates, prepared at ITM, contained 7H11 agar and oleic albumin dextrose catalase (BD 211886), plus amphotericin, piperacillin and trimethoprim (all at 4 lg/ml concentration) to reduce contamination. 9 Drug-containing wells contained final concentrations of 0.2 lg/ml INH, 1 lg/ml RMP, 2.0 lg/ml OFX (Sigma-Aldrich) and 6.0 lg/ml KM (ICN Biomedicals Inc, Aurora, OH, USA). MTC growth in MGIT, confirmed using SD-Bioline TB Ag MPT64 (Standard Diagnostic, Gyeonggi-do, Republic of Korea), was inoculated for INH and RMP DST in MGIT, following the manufacturer's instructions, and in parallel on Löwenstein-Jensen (LJ) for strain storage and for OFX and KM DST by the 7H11 agar indirect proportion method, according to international standards. The drug concentrations for DST on 7H11 agar were the same as for TLA, with resistance defined at a cut-off of 2.0 lg/ml for OFX and 6.0 lg/ mg for KM.
After inoculation, TLA plates were read on days 5, 7, 10, 13, 15, 20, 25, 30, 35, up to 40 days, adjusted to working days, using a conventional light microscope (objective 103). Growth in the GC well paired with inhibition in the PNB well was considered positive for MTC. 9 DST was interpreted if at least 10 colonies were present in the GC well; otherwise it was considered invalid. Drug resistance was defined as any growth in the drug wells. 7 TLA plates were read blinded to the MGIT and DST 7H11 agar results.
Discordant results were compared to a CRS consisting of MTBDRplus for INH and RMP, MTBDRsl for OFX, target gene sequencing (rpoB, katG, inhA, gyrAB and rrs 1400 region) and MIC, performed on LJ for INH and RMP, 7H11 agar for OFX and resazurin microtiter assay (REMA) for KM, with cut-offs at respectively 0.2 lg/ml, 40 lg/ml, 2 lg/ ml and 2.5 lg/ml. 10 Finally, the CRS also included comparison of the results from the paired sample of the same patient, confirmed to have the same genotype by spoligotyping, to exclude laboratory errors. Test costs were calculated using the manufacturer's price list and the FIND (Foundation for Innovative New Diagnostics, Geneva, Switzerland) website. Time for each test performance was calculated based on the ITM laboratory technician's estimates for each step.
RESULTS
Between November 2010 and February 2012, 362 smear-positive samples were received at the ITM from 183 consecutive patients (the Figure) . Of these, 42 (11.6%) were found to be smear-negative (S-) and excluded. The samples were decontaminated after a median of 12 days (interquartile range [IQR] 9-14) from collection. Of the 305 (95.3%) MTC-positive TLA plates, seven showed partial contamination, which did not prevent the interpretation of DST results. On MGIT, 306 (95.6%) cultures were positive, increasing to 313 (97.8%) after re-decontamination of seven partially contaminated MGIT cultures. Of 320 smear-positive samples, direct TLA yielded valid DST results in 89%, indirect MGIT in 97.5% and indirect 7H11 agar in 97.2% of the samples (Table 1) .
In total, 279 DST results were available for comparison for INH and RMP, with 35.1% resistance to either or both drugs, and 280 DST results for OFX and KM, with 8.2% resistant to either or both drugs. TLA sensitivity compared to indirect DST prior to resolution of discordances was respectively 92.3%, 96.4%, 83.3% and 57.9% for INH, RMP, OFX and KM, while specificity was 100% for all drugs, except OFX (99.6%) ( Table 2) . Discrepant results between TLA and MGIT or 7H11 medium were compared to the CRS (Table 3) . One discrepant DST result for INH and RMP was removed from the analysis, as spoligotyping was discordant between the sediment used for TLA and the isolate tested using MGIT.
INH DST results were initially discordant for six samples, all resistant on MGIT and susceptible on TLA. Five isolates that carried mutations in the KatG gene and showed an MIC above the cut-off were considered as false-susceptible on TLA. The sixth discrepancy was resolved in favour of TLA as the sediment was wild type (wt) by MDRTBplus and sequencing, the MIC was 0.1 lg/ml and the paired sample confirmed INH susceptibility in both TLA and MGIT. All INH-resistant results on TLA were concordant with MGIT. While smear positivity was similar (P ¼ 0.2), time to TLA GC positivity was significantly longer for discrepant DST results than concordant INH results (14 days, standard deviation (SD) 3.14 vs. 7 days, SD 3.51; P ¼ 0.04).
In the case of RMP, one sample was TLAsusceptible but MGIT-resistant. MTBDRplus detected an rpoB gene mutation, confirmed by sequencing as Leu531, while the MIC was .160 lg/ml. This sample was considered as false-susceptible on TLA. Of the eight OFX-resistant results in either technique, two were discrepant. One isolate that was TLAsusceptible but MGIT-resistant had a wt gyrA and gyrB profile on LPA and sequencing, with an MIC of 4 lg/ml, one dilution above the critical concentration. The paired isolate was susceptible on both techniques, confirming OFX susceptibility in favour of TLA. The sediment from the remaining isolate that was resistant on TLA and susceptible on indirect DST was not viable, and as the isolate was contaminated, it was not available for sequencing; however, the paired isolate was resistant by both techniques, confirming OFX resistance in TLA.
Of the eight discordant KM results, all TLAsusceptible and 7H11 agar-resistant, four were wt on sequencing, with MIC at 2.5 lg/ml. Two of these wt isolates belonged to the same patient. Another patient yielded KM-susceptible results by both techniques for the paired isolate, whereas for the remaining patient paired DST results were not available. These four discrepant results were resolved in favour of TLA. The remaining four samples showed an MIC 75 lg/ml, three were wt and one had an rrs A 1401 G mutation. All four samples were considered false-susceptible on TLA. To further investigate the reasons for the KM discrepancy, we established the MIC for all 11 concordant resistant results. All strains had an MIC of 75 lg/ml on REMA. Distribution of smear positivity grade and time to TLA GC positivity did not differ significantly in concordant and discordant results. After resolving the discrepancies, the corrected sensitivity of the TLA DST was respectively 94.7%, 98.2% 100% and 78.9% for INH, RMP, OFX and KM, with a specificity of 100% for all drugs (Table 4) .
Of the 115 patients who submitted two samples, 112 (97.4%) showed concordant TLA results on the paired samples, while three (2.6%) were discordant 
DISCUSSION
The study shows that direct TLA DST detects INH and RMP resistance reliably compared to the CRS, and represents the first attempt to apply TLA as a direct method to detect OFX and KM resistance, reducing the time to DST results from 72 to 7 days. TLA correctly detected OFX resistance when com- 12 Due to the high specificity, TLA results could be used to rapidly identify extensively drugresistant TB (XDR-TB) cases. Future studies on the optimisation of TLA performance for injectable agents can test the effect of a less diluted inoculum, a lower drug concentration, additional plate readings after prolonged incubation and comparing results between different injectables. The culture positivity rate for TLA and MGIT was respectively 95.3% and 97.8%, slightly higher than the 91.3% and 96.7% reported by Robledo et al. 6 Twenty TLA-positive cultures showed insufficient growth on GC to allow DST reading, with significantly lower microscopy positivity and longer sample processing delay than those with valid GC growth. Despite the significant impact of delay in sample processing on mycobacterial viability and DST interpretation, also reported by others, 13 contamination did not prevent interpretation of the plates. Robledo et al. found a contamination rate of 4.1%; this difference might be explained by our addition of the antibiotic mixture. One pair of samples yielded different spoligotype patterns, suggesting an administrative error, cross-contamination during MGIT DST inoculation or mixed infection in the patient.
Results for INH and RMP were slightly lower than the 100% sensitivity for both drugs on TLA reported by others; 6, 7 however, these studies included a limited number of drug-resistant samples. The study results are also in line with other noncommercial methods: respectively 97% and 98% for INH and RMP using CRI and MODS, and 91% and 97% with NRA, 5 while the specificity was less than 100% for all techniques. 5 Compared to other rapid methods, TLA sensitivity for INH was higher than MDRTBplus V.2 when applied to smearpositive samples (89.3%), 14 and comparable to MDRTBplus and Xpert (98.1% and 98.9%, respectively) for RMP detection. 15 All five false INH-susceptible isolates on TLA showed a high MIC, and the missed RMP-resistant isolate showed a 531Leu mutation, usually conferring high resistance levels. 16 False-susceptible results may be due to the slower growth of some strains, a short incubation time or the difficulty in standardising the inoculum for direct tests; however, only one sample was false-susceptible to more than one drug. To reduce the number of false-susceptible results, Schaberg et al. suggest limited dilution of the inoculum to ensure sufficient growth by diluting the sediment according to the sample microscopy grade. 7 In our study, the sediments had different positivity grades (Table 3) , but all were diluted 1:5 as resuspension.
TLA provides results considerably more quickly than conventional DST as well as the non-commercial direct DST methods (7 days for TLA vs. 10 days for NRA and 12 days for MODS). [17] [18] [19] Moreover, in contrast to conventional DST, TLA reduces the biohazard risk, as there is no need to open the plates; TLA can therefore be implemented in moderate-risk TB laboratories. 20 In addition, TLA is less expensive and presents a lower workload than gold standard techniques.
In conclusion, in low-resource settings where Xpert is not available, TLA could present an affordable alternative to LPA for the rapid detection of MDRand XDR-TB in high MDR-TB risk groups; in 
R E S U M E N M A R C O D E R E F E R E N C I A:
Las técnicas moleculares permiten un diagnóstico rá pido de la resistencia a rifampicina (RMP) e isoniazida (INH), pero no eliminan la necesidad de practicar pruebas de sensibilidad (DST) a otros medicamentos a partir de los cultivos. La prueba en agar de capa delgada (TLA) es un método directo no comercial de DST, que ha demostrado un buen rendimiento diagnóstico con respecto a la INH y la RMP aunque los datos existentes son limitados y se desconoce su aplicabilidad al ofloxacino (OFX) y la kanamicina (KM).
M É T O D O:
Se compararon 279 DST a INH y RMP en TLA con el método MGIT y 280 DST en TLA para OFX y KM, con el método de las proporciones en agar 7H11 usando 320 muestras de esputo con baciloscopia positiva, provenientes de 165 pacientes con diagnóstico de tuberculosis (TB) en Georgia. Se resolvieron las discordancias mediante la comparación con un patrón referencia compuesto. La prevalencia de multidrogorresistencia (MDR) fue de 30 en 164 pacientes (18,3%) y dos de ellos exhibieron TB extremadamente drogorresistente (6,7%). R E S U LTA D O S: La sensibilidad del método TLA con respecto a INH fue 94,7%, a RMP 98,2%, a OFX 100% y 78,9% a KM, con una especificidad de 100%. El lapso promedio hasta obtener los resultados fue 7 días con el método TLA, 23 días con el sistema MGIT y 49 días con el agar 7H11. C O N C L U S I Ó N: En los medios con escasos recursos es posible utilizar el método en TLA con el fin de detectar rá pidamente la resistencia a INH, RMP y las fluoroquinolonas. Se precisan nuevos estudios que permitan aumentar la sensibilidad en el diagnóstico de la resistencia a KM, evaluar mejor el rendimiento con respecto al OFX y otros medicamentos y estudiar la aplicabilidad de la prueba sobre el terreno.
